Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Type of study
Publication year range
1.
Acta Biomater ; 8(2): 549-58, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22051237

ABSTRACT

Controlling the non-specific adsorption of proteins, cells and bacteria onto biomaterial surfaces is of crucial importance for the development of medical devices with specific levels of performance. Among the strategies pursued to control the interactions between material surfaces and biological tissues, the immobilization of non-fouling polymers on biomaterial surfaces as well as the synthesis of the so-called biomimetic polymers are considered promising approaches to elicit specific cellular responses. In this study, in order to obtain materials able to prevent infectious and thrombotic complications related to the use of blood-contacting medical devices, heparin-mimetic segmented polyurethanes were synthesized and fully characterized. Specifically, sulfate or sulfamate groups, known to be responsible for the biological activity of heparin, were introduced into the side chain of a carboxylated polyurethane. Due to the introduction of these groups, the obtained polymers possessed a higher hard/soft phase segregation (lower glass transition temperatures) and a greater hydrophilicity than the pristine polymer. In addition, the synthesized polymers were able to significantly delay the activated partial thromboplastin time, this increased hemocompatibility being related both to polymer hydrophilicity and to the presence of the -SO3H groups. This last feature was also responsible for the ability of these biomimetic polymers to prevent the adhesion of a strain of Staphylococcus epidermidis.


Subject(s)
Biocompatible Materials/chemical synthesis , Biofouling/prevention & control , Biomimetic Materials/chemical synthesis , Polyurethanes/chemical synthesis , Anticoagulants/pharmacology , Bacterial Adhesion/drug effects , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Biomimetic Materials/chemistry , Biomimetic Materials/pharmacology , Calorimetry, Differential Scanning , Elastic Modulus/drug effects , Glass/chemistry , Humans , Magnetic Resonance Spectroscopy , Materials Testing , Partial Thromboplastin Time , Polyurethanes/chemistry , Polyurethanes/pharmacology , Staphylococcus epidermidis/cytology , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/ultrastructure , Tensile Strength/drug effects , Thermogravimetry , Transition Temperature/drug effects , Water/chemistry , Wettability/drug effects
2.
Acta Biomater ; 6(9): 3482-90, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20371306

ABSTRACT

In recent years the employment of implantable medical devices has increased remarkably, notwithstanding that microbial infections are a frequent complication associated with their use. Different strategies have been attempted to overcome this problem, including the incorporation of antimicrobial agents into the device itself. In this study a new approach to obtain intrinsically antimicrobial materials was developed. Polymer anionomers containing Ag(I), Cu(II), Zn(II), Al(III) and Fe(III) were prepared by neutralization of a carboxylated polyurethane. In the case of the PEUA-Ag, PEUA-Fe and PEUA-Cu ionomers the ion aggregates behaved as reinforcing filler particles, increasing the mechanical properties of the systems in terms of hardness and strength at break over the pristine carboxylated polymer. With the exception of the Al-containing polymer, all the other experimented ionomers showed satisfactory antimicrobial properties. The best antibacterial effect was obtained with the silver ion-containing polymer, which inhibited Staphylococcus epidermidis growth for up to 16days. Ciprofloxacin was also adsorbed onto the above mentioned ionomers. A synergistic effect of the antibiotic and silver ions on bacterial growth inhibition was observed for at least 25days.


Subject(s)
Anti-Infective Agents/pharmacology , Mechanical Phenomena/drug effects , Polyurethanes/pharmacology , Silver/pharmacology , Transition Temperature/drug effects , Adsorption/drug effects , Calorimetry, Differential Scanning , Ciprofloxacin/chemistry , Ciprofloxacin/pharmacology , Elastic Modulus/drug effects , Glass/chemistry , Ions , Microbial Sensitivity Tests , Polyurethanes/chemistry , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/growth & development , Staphylococcus epidermidis/ultrastructure , Stress, Mechanical , Tensile Strength/drug effects , Thermogravimetry , Water/chemistry
5.
Antimicrob Agents Chemother ; 51(8): 2733-40, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17548491

ABSTRACT

Antibiotic therapies to eradicate medical device-associated infections often fail because of the ability of sessile bacteria, encased in their exopolysaccharide matrix, to be more drug resistant than planktonic organisms. In the last two decades, several strategies to prevent microbial adhesion and biofilm formation on the surfaces of medical devices, based mainly on the use of antiadhesive, antiseptic, and antibiotic coatings on polymer surfaces, have been developed. More recent alternative approaches are based on molecules able to interfere with quorum-sensing phenomena or to dissolve biofilms. Interestingly, a newly purified beta-N-acetylglucosaminidase, dispersin B, produced by the gram-negative periodontal pathogen Actinobacillus actinomycetemcomitans, is able to dissolve mature biofilms produced by Staphylococcus epidermidis as well as some other bacterial species. Therefore, in this study, we developed new polymeric matrices able to bind dispersin B either alone or in combination with an antibiotic molecule, cefamandole nafate (CEF). We showed that our functionalized polyurethanes could adsorb a significant amount of dispersin B, which was able to exert its hydrolytic activity against the exopolysaccharide matrix produced by staphylococcal strains. When microbial biofilms were exposed to both dispersin B and CEF, a synergistic action became evident, thus characterizing these polymer-dispersin B-antibiotic systems as promising, highly effective tools for preventing bacterial colonization of medical devices.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/pharmacology , Biofilms/drug effects , Cefamandole/analogs & derivatives , Glycoside Hydrolases/pharmacology , Polyurethanes , Staphylococcus/drug effects , Anti-Bacterial Agents/chemistry , Bacterial Proteins/chemistry , Biofilms/growth & development , Cefamandole/chemistry , Cefamandole/pharmacology , Cell Line, Tumor , Drug Interactions , Glycoside Hydrolases/chemistry , Humans , Microbial Sensitivity Tests , Polyurethanes/chemistry , Prosthesis-Related Infections/prevention & control , Staphylococcus/growth & development , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/growth & development
6.
J Biomed Mater Res A ; 81(2): 287-98, 2007 May.
Article in English | MEDLINE | ID: mdl-17120216

ABSTRACT

Central venous catheters are a major cause of nosocomial bloodstream infections. Different attempts have been made to incorporate antimicrobial agents into catheters, particularly directed at the surface-coating of devices. To facilitate the antimicrobial adsorption, various cationic surfactants, which however showed several problems, have been used. On the other hand, impregnated catheters with only antimicrobials have demonstrated a short-term duration due to the difficulties to deliver the drug slowly. Thus, in order to obtain high antimicrobial-polymer affinity we synthesized or modified polyurethanes to introduce different functional groups. Polymers were loaded with two antibiotics, cefamandole nafate and rifampin (RIF), chosen for both their functional groups and their action spectrum. The in vitro release behavior showed that the elution of drugs depended on the matrix hydrophilicity and on the antibiotic-polymer and antibiotic-antibiotic interactions. To increase the amount of drug released, polyethylene glycol (PEG) used as a pore forming agent at different molecular weights was incorporated in the polymer bulk with antibiotics. As for the in vitro antimicrobial activity of matrices, assessed by Kirby-Bauer test, it was seen that antibiotics released from various formulations inhibited the bacterial growth and exerted a synergistic effect when both were present. In particular, PEG10000-containing polymer was active against the RIF-resistant S. aureus strain up to 23 days. These results suggest that the combined entrapping of antibiotics and pore formers in these novel polymer systems could be promising to prevent the bacterial colonization and to control the emergence of bacterial resistance.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Biocompatible Materials/chemical synthesis , Drug Delivery Systems , Polyurethanes , Bacterial Adhesion/drug effects , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/instrumentation , Cell Line , Cross Infection/prevention & control , Delayed-Action Preparations , Drug Resistance, Bacterial , Humans , In Vitro Techniques , Materials Testing , Polyurethanes/chemical synthesis , Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects
7.
J Appl Microbiol ; 100(3): 615-22, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16478501

ABSTRACT

AIMS: As a preventive strategy to inhibit fungal biofilm formation on medical devices, we planned experiments based on polyurethane loading with fluconazole plus pore-former agents in order to obtain a promoted release of the antifungal drug. METHODS AND RESULTS: Different functional groups including carboxyl, hydroxyl, primary and tertiary amino groups, were introduced in polyurethanes. Fluconazole was adsorbed in higher amounts by the most hydrophilic polymers and its release was influenced by the degree of polymer swelling in water. The entrapping in the polymer of polyethylenglycol as a pore former significantly improved the fluconazole release while the entrapping of the higher molecular weight porogen albumin resulted in a controlled drug release and in an improved antifungal activity over time. CONCLUSIONS: Among the tested in vitro models, best results were achieved with an hydrophobic polymer impregnated with 25% (w/w) albumin and fluconazole which inhibited Candida albicans growth and biofilm formation on polymeric surfaces up to 8 days. SIGNIFICANCE AND IMPACT OF THE STUDY: The combined entrapping in polymers of pore formers and an antifungal drug and the consequent controlled release over time is a novel, promising approach in the development of medical devices refractory to fungal colonization.


Subject(s)
Antifungal Agents/administration & dosage , Biofilms , Candida albicans/drug effects , Fluconazole/administration & dosage , Polyurethanes , Adsorption , Antifungal Agents/pharmacokinetics , Candida albicans/growth & development , Candidiasis/prevention & control , Catheterization, Central Venous/instrumentation , Delayed-Action Preparations/administration & dosage , Drug Carriers , Fluconazole/pharmacokinetics , Humans , Microscopy, Electron, Scanning/methods , Polyethylene Glycols , Prosthesis-Related Infections/prevention & control , Serum Albumin, Bovine
8.
Antimicrob Agents Chemother ; 49(10): 4272-9, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16189108

ABSTRACT

Indwelling prostheses and subcutaneous delivery devices are now routinely and indispensably employed in medical practice. However, these same devices often provide a highly suitable surface for bacterial adhesion and colonization, resulting in the formation of complex, differentiated, and structured communities known as biofilms. The University of Washington Engineered Biomaterials group has developed a novel drug delivery polymer matrix consisting of a poly(2-hydroxyethyl methacrylate) hydrogel coated with ordered methylene chains that form an ultrasound-responsive coating. This system was able to retain the drug ciprofloxacin inside the polymer in the absence of ultrasound but showed significant drug release when low-intensity ultrasound was applied. To assess the potential of this controlled drug delivery system for the targeting of infectious biofilms, we monitored the accumulation of Pseudomonas aeruginosa biofilms grown on hydrogels with and without ciprofloxacin and with and without exposure to ultrasound (a 43-kHz ultrasonic bath for 20 min daily) in an in vitro flow cell study. Biofilm accumulation from confocal images was quantified and statistically compared by using COMSTAT biofilm analysis software. Biofilm accumulation on ciprofloxacin-loaded hydrogels with ultrasound-induced drug delivery was significantly reduced compared to the accumulation of biofilms grown in control experiments. The results of these studies may ultimately facilitate the future development of medical devices sensitive to external ultrasonic impulses and capable of treating or preventing biofilm growth via "on-demand" drug release.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Biofilms , Ciprofloxacin/pharmacokinetics , Coated Materials, Biocompatible/chemistry , Pseudomonas Infections/prevention & control , Ultrasonics , Biofilms/drug effects , Biofilms/growth & development , Hydrogels/chemistry , Methacrylates/chemistry , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development
9.
J Chemother ; 16(5): 446-52, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15565910

ABSTRACT

Acidic or basic polyurethanes were loaded with antibiotics to develop materials to prevent medical device-related infections. A correlation between polymer-antibiotic interactions and amount of drug absorbed by polymers and released over time was found. Since the employed antibiotics, i.e. amoxicillin, cefamandole nafate, rifampin and vancomycin, possessed at least an acidic group in their structural formula, the introduction of basic tertiary amines in the polyurethane side-chain resulted in an increased polymer ability to adsorb antibiotics. However, a stronger ionic interaction between this polymer and the antibiotics caused a release of lower amount of drug over time. Antibiotics released from polymers inhibited Staphylococcus epidermidis growth on agar. Antibiotic-loaded polyurethanes kept in water for increasing times were still able to show inhibition zones of bacterial growth. The antibacterial activity lasted up to 3 hours for amoxicillin, 24 hours for vancomycin, 8 days for cefamandole nafate and 8 months for rifampin.


Subject(s)
Anti-Bacterial Agents/pharmacology , Polyurethanes/chemistry , Staphylococcus epidermidis/drug effects , Amoxicillin/chemistry , Amoxicillin/pharmacology , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/chemistry , Cefamandole/chemistry , Cefamandole/pharmacology , Drug Interactions , Humans , Infusions, Intravenous , Microbial Sensitivity Tests , Rifampin/chemistry , Rifampin/pharmacology , Vancomycin/chemistry , Vancomycin/pharmacology
10.
Antimicrob Agents Chemother ; 48(11): 4360-5, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15504865

ABSTRACT

In modern medicine, artificial devices are used for repair or replacement of damaged parts of the body, delivery of drugs, and monitoring the status of critically ill patients. However, artificial surfaces are often susceptible to colonization by bacteria and fungi. Once microorganisms have adhered to the surface, they can form biofilms, resulting in highly resistant local or systemic infections. At this time, the evidence suggests that (+)-usnic acid, a secondary lichen metabolite, possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium. Since lichens are surface-attached communities that produce antibiotics, including usnic acid, to protect themselves from colonization by other bacteria, we hypothesized that the mode of action of usnic acid may be utilized in the control of medical biofilms. We loaded (+)-usnic acid into modified polyurethane and quantitatively assessed the capacity of (+)-usnic acid to control biofilm formation by either S. aureus or Pseudomonas aeruginosa under laminar flow conditions by using image analysis. (+)-Usnic acid-loaded polymers did not inhibit the initial attachment of S. aureus cells, but killing the attached cells resulted in the inhibition of biofilm. Interestingly, although P. aeruginosa biofilms did form on the surface of (+)-usnic acid-loaded polymer, the morphology of the biofilm was altered, possibly indicating that (+)-usnic acid interfered with signaling pathways.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Benzofurans/pharmacology , Bacterial Adhesion/drug effects , Biofilms/drug effects , Green Fluorescent Proteins , Microscopy, Confocal , Polymers , Polyurethanes , Staphylococcus aureus/drug effects , Surface Properties
11.
Int J Pharm ; 280(1-2): 173-83, 2004 Aug 06.
Article in English | MEDLINE | ID: mdl-15265557

ABSTRACT

Intravascular devices are widely used for vascular access but are associated with substantial risk of development of devices-related bloodstream infection (DR-BSI), which causes a considerable increase of morbidity and mortality, prolonged hospitalisation and growing medical costs. Since conventional treatment of DR-BSI fails in a significant number of cases, resulting in removal of the device, new approaches are needed to prevent bacterial colonization. In this paper, two antibiotics, rifampin and amoxicillin, have been adsorbed on polyurethanes exhibiting acidic or basic properties. The influence of the type of antibiotic-polymer interaction on the amount of adsorbed antibiotic and on the release kinetics was studied. It was seen that the antibiotic-polymer affinity increases both with the introduction in the polymer side-chain of functional groups and with the matrix hydrophilicity. The antimicrobial activity of the treated polymers, evaluated in vitro by the Kirby-Bauer test, depends on the amount of antibiotic adsorbed, on the strength of drug-matrix interaction and on the water swelling of the polymers. The inhibition zone of bacterial growth lasts only a few hours for the amoxi-coated polymers while remains at least for five months for the rifampin-coated ones. The presence of serum proteins decreases by about 30% the inhibition zone diameter of these latest matrices after two months.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Equipment Contamination/prevention & control , Polyurethanes/administration & dosage , Adsorption/drug effects , Amoxicillin/administration & dosage , Bacterial Infections/prevention & control , Colony Count, Microbial/methods , Rifampin/administration & dosage , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/growth & development
12.
J Chemother ; 14(5): 501-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12462430

ABSTRACT

Intravascular catheters are widely employed in medical practice. However, complications such as local or systemic infections are frequently related to their use. The significant increase in this type of nosocomial infection has prompted the search for new strategies to prevent them. This paper reports on an experimental model to prevent catheter-related infections based on the adsorption of a beta-lactam antibiotic (cefamandole nafate) on functionalized urethane polymers. The polyurethanes synthesized were used to coat a commercial central venous catheter. The influence of functional groups on the polymer-antibiotic interaction was analyzed and the kinetics of the antibiotic release from the catheters was dynamically studied. We were able to realize a polymer-antibiotic system able to inhibit bacterial growth up to 7 days. These promising results have encouraged us to extend this experimental model to other polymer-antibiotic systems in order to identify those allowing bacterial growth inhibition for longer times.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacokinetics , Biofilms , Catheterization, Central Venous/adverse effects , Cefamandole/administration & dosage , Cefamandole/pharmacokinetics , Bacterial Infections/prevention & control , Drug Delivery Systems , Humans , Polymers
13.
J Chemother ; 13(6): 595-606, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11806619

ABSTRACT

In recent years, central venous catheters (CVCs) are increasingly used in clinical practice. However, complications such as local or systemic infections are frequent for both temporary and indwelling vascular catheters. Annually, in the United States of America there are more than 200,000 cases of nosocomial bloodstream infections (BSIs), of which 90% are related to the use of an intravascular device. These infections are associated with increased morbidity and mortality, prolonged hospitalization and growing medical costs. Technological treatments of polymer surfaces including coating the catheter with antimicrobial substances may be promising tools for prevention of catheter-associated infections. A large number of surface-treated central venous catheters are now commercially available. In this paper the features and the clinical efficacy of different antimicrobial coatings are reviewed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Infective Agents, Local/pharmacology , Bacterial Adhesion/drug effects , Bacterial Infections/prevention & control , Catheterization, Central Venous/adverse effects , Benzalkonium Compounds/pharmacology , Catheterization, Central Venous/instrumentation , Chlorhexidine/pharmacology , Humans , Silver/pharmacology , Silver Sulfadiazine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...